MediciNova Inc (MNOV)
2.13
+0.13
(+6.50%)
USD |
NASDAQ |
Nov 22, 16:00
2.13
0.00 (0.00%)
Pre-Market: 09:28
MediciNova Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -72.31% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | -9.54K% |
| June 30, 2021 | |
| March 31, 2021 | -4.70% |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 |
| Date | Value |
|---|---|
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 56.89% |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | -74.27K% |
| December 31, 2012 | -7.16K% |
| September 30, 2012 | -2.84K% |
| June 30, 2012 | -462.2% |
| March 31, 2012 | -2.02K% |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-9.54K%
Minimum
Sep 2021
-4.70%
Maximum
Mar 2021
-3.21K%
Average
-72.31%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| BioVie Inc | -- |
| BridgeBio Pharma Inc | -5.93K% |
| Ikena Oncology Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |